{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:29:49Z","timestamp":1789734589073,"version":"4.0.1"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,10,27]]},"DOI":"10.1001\/jama.2020.16167","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:01:05Z","timestamp":1603796465000},"page":"1640","source":"Crossref","is-referenced-by-count":150,"title":["Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1001","volume":"324","author":[{"given":"Seng Chan","family":"You","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea"},{"name":"Observational Health Data Sciences and Informatics, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeunsook","family":"Rho","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Health Insurance Review and Assessment Service, Wonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnood","family":"Bikdeli","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Division of Cardiology, Department of Medicine, Columbia University Medical Center\/New York-Presbyterian Hospital, New York, New York"},{"name":"Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut"},{"name":"Cardiovascular Research Foundation (CRF), New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwoo","family":"Kim","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Health Insurance Review and Assessment Service, Wonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Siapos","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Real World Evidence Solutions, IQVIA, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Weaver","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Londhe","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Janssen Research and Development, Titusville, New Jersey"},{"name":"Now with Amgen, Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyeong","family":"Cho","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimyung","family":"Park","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Schuemie","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey"},{"name":"Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Suchard","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles"},{"name":"Department of Biomathematics, David Geffen School of Medicine at UCLA, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Madigan","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Department of Statistics, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Hripcsak","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Department of Biomedical Informatics, Columbia University, New York, New York"},{"name":"Medical Informatics Services, New York-Presbyterian Hospital, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakriti","family":"Gupta","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Division of Cardiology, Department of Medicine, Columbia University Medical Center\/New York-Presbyterian Hospital, New York, New York"},{"name":"Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut"},{"name":"Cardiovascular Research Foundation (CRF), New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Reich","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Real World Evidence Solutions, IQVIA, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey"},{"name":"Department of Biomedical Informatics, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae Woong","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea"},{"name":"Observational Health Data Sciences and Informatics, New York, New York"},{"name":"Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlan M.","family":"Krumholz","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut"},{"name":"Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"25","key":"joi200094r1","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study.","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"issue":"10","key":"joi200094r2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"68","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"joi200094r3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"issue":"11","key":"joi200094r4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes.","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"joi200094r5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/imj.13041","article-title":"Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention.","volume":"46","author":"Yudi","year":"2016","journal-title":"Intern Med J"},{"issue":"1","key":"joi200094r6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ehjcvp\/pvv034","article-title":"Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).","volume":"2","author":"Sahl\u00e9n","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"7","key":"joi200094r7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamainternmed.2018.0783","article-title":"Trends in platelet adenosine diphosphate P2Y12 receptor inhibitor use and adherence among antiplatelet-naive patients after percutaneous coronary intervention, 2008-2016.","volume":"178","author":"Dayoub","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"5","key":"joi200094r8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.111.047498","article-title":"Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial.","volume":"124","author":"Mahaffey","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"joi200094r9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jamacardio.2016.1017","article-title":"Long-term tolerability of ticagrelor for the secondary prevention of major adverse cardiovascular events: a secondary analysis of the PEGASUS-TIMI 54 trial.","volume":"1","author":"Bonaca","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"2","key":"joi200094r10","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000479","article-title":"Systematic reviews: causes of non-adherence to P2Y12 inhibitors in acute coronary syndromes and response to intervention.","volume":"3","author":"Johnston","year":"2016","journal-title":"Open Heart"},{"issue":"3","key":"joi200094r11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamainternmed.2019.6447","article-title":"Association of ticagrelor vs clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.","volume":"180","author":"Turgeon","year":"2020","journal-title":"JAMA Intern Med"},{"key":"joi200094r12","first-page":"574","article-title":"Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers.","volume":"216","author":"Hripcsak","year":"2015","journal-title":"Stud Health Technol Inform"},{"issue":"1","key":"joi200094r13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/amiajnl-2011-000376","article-title":"Validation of a common data model for active safety surveillance research.","volume":"19","author":"Overhage","year":"2012","journal-title":"J Am Med Inform Assoc"},{"issue":"10211","key":"joi200094r14","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/S0140-6736(19)32317-7","article-title":"Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.","volume":"394","author":"Suchard","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"joi200094r16","doi-asserted-by":"crossref","DOI":"10.1145\/2414416.2414791","article-title":"Massive parallelization of serial inference algorithms for a complex generalized linear model.","volume":"23","author":"Suchard","year":"2013","journal-title":"ACM Trans Model Comput Simul"},{"issue":"6","key":"joi200094r17","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/ije\/dyy120","article-title":"Evaluating large-scale propensity score performance through real-world and synthetic data experiments.","volume":"47","author":"Tian","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"3","key":"joi200094r18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"3","key":"joi200094r19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"44","key":"joi200094r20","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1093\/eurheartj\/ehw284","article-title":"Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry.","volume":"37","author":"Sahl\u00e9n","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"joi200094r21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies.","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"key":"joi200094r22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jbi.2016.12.005","article-title":"Accuracy of an automated knowledge base for identifying drug adverse reactions.","volume":"66","author":"Voss","year":"2017","journal-title":"J Biomed Inform"},{"issue":"2","key":"joi200094r23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/sim.5925","article-title":"Interpreting observational studies: why empirical calibration is needed to correct P values.","volume":"33","author":"Schuemie","year":"2014","journal-title":"Stat Med"},{"issue":"23","key":"joi200094r24","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes.","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"issue":"23","key":"joi200094r25","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/CIRCULATIONAHA.119.041766","article-title":"Clinically significant bleeding with ticagrelor versus clopidogrel in Korean patients with acute coronary syndromes intended for invasive management: a randomized clinical trial.","volume":"140","author":"Park","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"joi200094r27","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1253\/circj.CJ-15-0112","article-title":"Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome\u2014randomized, double-blind, phase III PHILO study.","volume":"79","author":"Goto","year":"2015","journal-title":"Circ J"},{"issue":"10233","key":"joi200094r28","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0140-6736(20)30325-1","article-title":"Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.","volume":"395","author":"Gimbel","year":"2020","journal-title":"Lancet"},{"key":"joi200094r29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2018.03.116","article-title":"High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and clopidogrel or ticagrelor: insights from change DAPT.","volume":"268","author":"Zocca","year":"2018","journal-title":"Int J Cardiol"},{"issue":"17","key":"joi200094r30","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.4103\/0366-6999.239306","article-title":"Impact of baseline bleeding risk on efficacy and safety of ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention.","volume":"131","author":"Wang","year":"2018","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"joi200094r31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCOUTCOMES.114.001223","article-title":"Early medication nonadherence after acute myocardial infarction: insights into actionable opportunities from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study.","volume":"8","author":"Mathews","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"41","key":"joi200094r32","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1093\/eurheartj\/ehx175","article-title":"Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study.","volume":"38","author":"Cuisset","year":"2017","journal-title":"Eur Heart J"},{"issue":"10151","key":"joi200094r33","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","article-title":"Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.","volume":"392","author":"Vranckx","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"joi200094r34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jacc.2017.11.008","article-title":"1-year outcomes of patients undergoing primary angioplasty for myocardial infarction treated with prasugrel versus ticagrelor.","volume":"71","author":"Motovska","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"joi200094r35","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/eurheartj\/ehz593","article-title":"Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry.","volume":"41","author":"Simonsson","year":"2020","journal-title":"Eur Heart J"},{"issue":"10190","key":"joi200094r36","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0140-6736(19)30474-X","article-title":"Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials.","volume":"393","author":"Piccolo","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"joi200094r37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11239-019-01860-7","article-title":"De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis.","volume":"48","author":"Angiolillo","year":"2019","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"joi200094r38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3109\/09537104.2015.1119815","article-title":"Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry.","volume":"27","author":"Biscaglia","year":"2016","journal-title":"Platelets"},{"issue":"2","key":"joi200094r39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ccd.27145","article-title":"The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: insights from the TRANSLATE-ACS study.","volume":"91","author":"Effron","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"issue":"16","key":"joi200094r40","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes.","volume":"381","author":"Sch\u00fcpke","year":"2019","journal-title":"N Engl J Med"},{"key":"joi200094r15","unstructured":"You? SC. GitHub website. OHDSI network study: net adverse clinical event between ticagrelor and clopidogrel in patients with acute coronary syndrome. Accessed October 6, 2020.? https:\/\/github.com\/ohdsi-studies\/TicagrelorVsClopidogrel"},{"key":"joi200094r26","unstructured":"You? SC. GitHub website. OHDSI network study: whole balance data before and after propensity score adjustment for more than 10 000 baseline covariates in each database. Accessed October 6, 2020. https:\/\/github.com\/OHDSI\/ShinyDeploy\/tree\/master\/TicagrelorVsClopidogrel\/data"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2772280\/jama_you_2020_oi_200094_1603319690.60891.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:01:44Z","timestamp":1603796504000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2772280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":40,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2020,10,27]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.16167","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,27]]}}}